Glenmark Pharmaceuticals
GLENMARK.NS
#2222
Rank
NZ$14.74 B
Marketcap
NZ$52.23
Share price
1.51%
Change (1 day)
41.08%
Change (1 year)

Earnings for Glenmark Pharmaceuticals (GLENMARK.NS)

Earnings in 2026 (TTM): NZ$0.39 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings are NZ$1.68 Billion. In 2025 the company made an earning of NZ$0.37 Billion a decrease over its 2024 earnings that were of NZ$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Glenmark Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.39 B4.18%
2025 NZ$0.37 B-21.28%
2024 NZ$0.48 B-529.79%
2023 -NZ$0.12 Billion-129.24%
2022 NZ$0.38 B-14%
2021 NZ$0.44 B4.73%
2020 NZ$0.42 B19.04%
2019 NZ$0.35 B-16.09%
2018 NZ$0.42 B36.39%
2017 NZ$0.31 B-31.75%
2016 NZ$0.45 B66.33%
2015 NZ$0.27 B9.02%
2014 NZ$0.25 B-18.61%
2013 NZ$0.30 B3.8%
2012 NZ$0.29 B